ENTX

Entera Bio Ltd. (ENTX) Economic Moat Analysis (2026)

Invetso Score: 1.9/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 2.4 (Weak)

ENTX appears to have limited intangible-asset protection because the provided metrics show deeply negative ROIC and ROCE, which indicates it is not converting any presumed IP or brand into durable pricing power versus peers.

No filing-based evidence was provided for patents, proprietary formulations, or regulatory exclusivity, so there is no visible structural barrier that would let ENTX defend margins better than peers over 5–10 years.

Compared with peers that have protected IP or approved products, ENTX looks materially weaker because the available data do not show monetizable exclusivity or sustained returns on capital.

The absence of positive capital returns suggests any intangible advantage, if present, is not strong enough to translate into durable economics relative to competitors.

Switching Costs

Score:

The negative ROIC and ROCE imply customers are not locked in by high switching costs, because a business with meaningful lock-in typically retains pricing power and earns positive excess returns.

No evidence was provided of long-term contracts, workflow integration, or regulatory dependence that would make ENTX harder to replace than peers.

Compared with peers that benefit from embedded products or recurring usage, ENTX shows no sign of customer captivity in the supplied data.

The extremely weak efficiency profile is consistent with low retention power, which means switching costs are not currently supporting durability.

Network Effects

Score:

The supplied metrics do not indicate any network-driven flywheel, because network effects usually show up in improving unit economics and stronger capital returns over time.

ENTX’s negative ROIC and ROCE argue against a self-reinforcing ecosystem, since network effects should generally improve monetization as scale rises.

Compared with peers that benefit from user density, data accumulation, or platform liquidity, ENTX shows no evidence of comparable peer-dependent demand.

There is no provided evidence that customers, partners, or suppliers become more valuable to each other through ENTX’s platform, so network effects appear absent.

Cost Advantage

Score:

The company’s negative ROIC and ROCE indicate it is not operating with a visible cost advantage, because a lower-cost structure should support positive returns versus peers.

Asset turnover of 0 in the provided data suggests the business is not efficiently converting assets into revenue, which weakens any claim to structural cost leadership.

Compared with peers that can spread fixed costs or source inputs more efficiently, ENTX shows no evidence of superior unit economics in the supplied metrics.

The negative cash conversion cycle alone does not establish cost advantage, because the broader profitability profile shows the business is not translating working-capital dynamics into durable margin strength.

Efficient Scale

Score:

ENTX does not show signs of efficient scale in the provided data, because efficient-scale moats usually support positive returns in a niche where one or two firms can profitably serve demand.

The deeply negative ROIC and ROCE suggest the company is not capturing a protected niche with enough pricing power to deter peers from competing away returns.

Compared with peers in concentrated markets, ENTX appears to lack evidence of industry structure that would limit competition and preserve margins.

No filing evidence was provided showing regulated scarcity, exclusive access, or a natural monopoly-like position, so efficient scale is not supported.

Overall Score

Score:

ENTX shows no demonstrated durable moat in the supplied evidence, because every structural driver is weak and the negative return profile indicates materially inferior pricing power and retention versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Entera Bio Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →